Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Debenture Conversion and Warrant buyback

http://www.hawkassociates.com/clients/press/full_news.cfm?client_id=12&news_id=944

This was followed by the Dividend payouts,in which Schwartz/Lincoln received dividends,

on the warrants as well as their stock..(Converted debentures)...Neat HUH.??

Share
New Message
Please login to post a reply